These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6301117)

  • 1. Preliminary results of a randomized comparison of cyclosporine and Minnesota Antilymphoblast Globulin.
    Halloran PF; Lien J; Aprile M; White N
    Transplant Proc; 1982 Dec; 14(4):627-30. PubMed ID: 6301117
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonsteroid treatment of rejection in kidney transplantation. A new approach including long-term treatment of rejection with antilymphoblast globulin in a high risk population.
    Toledo-Pereyra LH; Mittal VK; Baskin S; McNichol LJ; Whitten JI
    Transplantation; 1982 Mar; 33(3):325-7. PubMed ID: 6801834
    [No Abstract]   [Full Text] [Related]  

  • 3. Antilymphoblast globulin treatment of steroid-resistant rejection in cyclosporine-immunosuppressed renal transplant recipients.
    Tellis VA; Matas AJ; Quinn TA; Glicklich D; Weiss RJ; Soberman RJ; Veith FJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1892. PubMed ID: 3274447
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.
    Kitabayashi K; Munn SR; Sterioff S
    Transplant Proc; 1996 Jun; 28(3):1973-5. PubMed ID: 8658964
    [No Abstract]   [Full Text] [Related]  

  • 5. Sequential Minnesota antilymphoblast globulin and cyclosporine therapy after cadaver renal transplantation.
    Ludwin D; White N; Tsai S; Smith EK
    Transplant Proc; 1985 Aug; 17(4):1943-4. PubMed ID: 3895635
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of cyclosporine and Minnesota antilymphoblast globulin in the early postoperative treatment of primary cadaveric renal transplant recipients.
    Kupin W; Venkat KK; Oh HK; Dienst S; Levin NW
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1882-5. PubMed ID: 3547893
    [No Abstract]   [Full Text] [Related]  

  • 7. Preliminary results of a prospective randomized clinical trial comparing cyclosporine A to antithymocyte globulin immunosuppressive induction therapy in kidney transplantation.
    Banhegyi C; Rockenschaub S; Mühlbacher F; Kovarik J; Balcke P; Götzinger P; Wamser P
    Transplant Proc; 1991 Aug; 23(4):2207-8. PubMed ID: 1871846
    [No Abstract]   [Full Text] [Related]  

  • 8. High long-term graft survival rates in kidney transplantation with the sequential association of antithymocyte globulin and cyclosporine A monotherapy.
    Hourmant M; Buzelin F; Dubigeon P; Soulillou JP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2113-4. PubMed ID: 3079073
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcome of cadaveric renal transplantation by induction treatment in the cyclosporine era.
    Hariharan S; Alexander JW; Schroeder TJ; First MR
    Clin Transplant; 1996 Apr; 10(2):186-90. PubMed ID: 8664516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
    Gianello P; Squifflet JP; Pirson Y; Stoffel M; Dereme T; Alexandre GP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
    [No Abstract]   [Full Text] [Related]  

  • 11. Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine.
    Canafax DM; Simmons RL; Sutherland DE; Fryd DS; Strand MH; Ascher NL; Payne WD; Najarian JS
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):192-6. PubMed ID: 3515687
    [No Abstract]   [Full Text] [Related]  

  • 12. Results of renal transplantation in diabetics at the University of Minnesota since 1979, including a comparison of outcome in diabetic and nondiabetic recipients randomized to cyclosporine versus azathioprine for immunosuppression.
    Sutherland DE; Fryd DS; Strand M; Ascher N; Simmons RL; Najarian JS
    Transplant Proc; 1984 Jun; 16(3):629-32. PubMed ID: 6375030
    [No Abstract]   [Full Text] [Related]  

  • 13. Has cyclosporine really relegated pretransplant blood transfusions to therapeutic obsolescence?
    Melzer JS; Husing RM; Feduska NJ; Tomlanovich SJ; Vincenti F; Amend WJ; Garovoy M; Salvatierra O
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1971-3. PubMed ID: 2856274
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
    Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG
    Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of cytomegalovirus infection and immunosuppressive treatment with cyclosporine A and antilymphocyte globulin in renal transplant recipients.
    Peraldi MN; Rondeau E; Bellaj A; Kanfer A; Sraer JD
    Clin Nephrol; 1988 Jan; 29(1):52. PubMed ID: 2838205
    [No Abstract]   [Full Text] [Related]  

  • 16. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
    Cantarovich M; Durrbach A; Hiesse C; Ladouceur M; Benoit G; Charpentier B
    Transplantation; 2008 Dec; 86(12):1732-7. PubMed ID: 19104413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
    Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM
    Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective randomized comparison of antilymphoblast globulin versus antithymocyte globulin for cadaver kidney transplantation.
    Toledo-Pereyra LH; Bergren C; Mittal VK; Whitten JI; Baskin S; McNichol L
    Transplantation; 1985 Oct; 40(4):448-50. PubMed ID: 3901446
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimal results in cadaveric renal transplantation with low-dose cyclosporine and steroids combined with prophylactic anti-lymphocyte globulin.
    Fries D; Hiesse C; Charpentier B; Cantarovich M; Lantz O; Benoit G
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):23-5. PubMed ID: 3051581
    [No Abstract]   [Full Text] [Related]  

  • 20. Peri-operative antilymphoblast globulin (ALG) and delayed initiation of cyclosporine (CsA) diminishes the requirement for prolonged dialysis therapy after renal transplantation.
    Nestor ZJ; Rocher LL; Merion RM; Swartz RD; Turcotte JG; Campbell DA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1556-7. PubMed ID: 2652505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.